Schwab Andrew J. Insider Trades & Stock Holdings

Director · Skye Bioscience, Inc. · Latest filing Sep 23, 2026

Schwab Andrew J., Director at Skye Bioscience, Inc. has 3 Form 4 trades on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 3 sales ($304.29K), net -$304.29K. Latest filing: disposed of 119.38K shares of $SKYE on Sep 23, 2026 at $1.61.

Trades on file

3

Open-market bought

$0

Open-market sold

$304.29K

Net open-market

-$304.29K

Latest filing

Sep 23, 2026

All insider trades by Schwab Andrew J.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 23, 2026	$SKYE	Sell (Open-market sale)	119.38K	$1.61	$192.20K			-10.6%			Director		—
Sep 22, 2026	$SKYE	Sell (Open-market sale)	28.70K	$1.65	$47.35K			-7.0%			Director		—
Sep 16, 2026	$SKYE	Sell (Open-market sale)	33.89K	$1.91	$64.73K			+5.9%	-8.8%		Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Schwab Andrew J. traded

• $SKYE

Frequently asked questions

Has Schwab Andrew J. been buying or selling stock?

Schwab Andrew J. has 0 open-market purchases and 3 open-market sales on file, net -$304.29K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Schwab Andrew J.'s latest insider trade?

disposed of 119.38K shares of $SKYE on Sep 23, 2026 at $1.61.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.